Qualigen Therapeutics Inc.
QLGN | NASDAQ
$3.21
+$0.17 (+5.59%)
At close: Nov 18, 2025, 04:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.63M | 3.23M | 3.23M | 4.68M | 4.48M | 3.59M | 5.07M | 4.79M | 4.48M | 5.65M | 5.28M | 4.96M | 4.75M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 754.29K | 1.12M | 1.12M | 2.56M | 2.83M | 3.73M | 3.73M | 3.56M | 3.65M | 3.21M | 4.43M | 4.14M | 3.96M | 4.33M | 5.87M | 5.8M | 5.69M |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -754.29K | -1.12M | -1.12M | -2.56M | -1.2M | -493.26K | -491.81K | 1.11M | 833.19K | 384.03K | 648.04K | 646.95K | 517.41K | 1.32M | -590.58K | -836.28K | -941.45K |
Operating Income | -16.09M | -14.81M | -13.2M | -7.17M | -7.01M | -7.07M | -5.76M | -6.71M | -8.21M | -10.03M | -12.3M | -13.46M | -15.06M | -15.65M | -16.97M | -18.18M | -18.61M | -21.86M | -22.66M | -23.62M | -22.53M | -17.71M |
Interest Income | 331.02K | 346.54K | 156.48K | 529.96K | 384.23K | 242.84K | 129.89K | 49.18K | 1.09K | n/a | n/a | n/a | 4.63K | 9.46K | 15.76K | 21.6K | 23.77K | 31.66K | 42.69K | 46.9K | 40.1K | 27.38K |
Pretax Income | -22.9M | -20.4M | -16.97M | -7.22M | -6.98M | -6.77M | -6.16M | -7.78M | -9.22M | -11.31M | -13.55M | -14.68M | -15.5M | -16.05M | -16.1M | -18.55M | -17.36M | -18.54M | -17.89M | -4.69M | -9.94M | -23.22M |
Net Income | -25.46M | -22.96M | -19.53M | -7.23M | -6.98M | -6.87M | -6.26M | -7.87M | -9.73M | -11.62M | -13.7M | -17.6M | -17.77M | -18.43M | -18.64M | -18.33M | -17.37M | -18.54M | -17.9M | -4.69M | -9.95M | -23.22M |
Selling & General & Admin | 11.61M | 10.32M | 8.82M | 7.06M | 6.88M | 6.2M | 4.57M | 4.15M | 4.34M | 6.19M | 7.04M | 8.65M | 10.17M | 10.3M | 11.43M | 12.14M | 12.17M | 12.29M | 12.27M | 11.57M | 11.44M | 10.42M |
Research & Development | 143.96K | 156.7K | 184.8K | 111.62K | 129.47K | 865.94K | 1.2M | 2.55M | 3.87M | 4.44M | 6.2M | 5.76M | 6M | 6.18M | 5.93M | 6.68M | 7.08M | 10.08M | 11.72M | 11.94M | 10.73M | 6.82M |
Other Expenses | 142.57K | 142.57K | n/a | n/a | n/a | -754.29K | -1.12M | -1.12M | -2.56M | -1.8M | -1.43M | -1.43M | 11.7K | 5.64K | 763 | 2.61K | 2.18K | 4.9K | 5.45K | -468.28K | -466.54K | -468.89K |
Operating Expenses | 11.89M | 10.62M | 9.01M | 7.17M | 7.01M | 6.31M | 4.65M | 5.58M | 5.65M | 8.83M | 11.8M | 12.97M | 16.18M | 16.49M | 17.35M | 18.83M | 19.25M | 22.38M | 23.98M | 23.03M | 21.7M | 16.77M |
Interest Expense | 808.83K | 914.89K | 988.5K | 736.07K | 688.49K | 846K | 908.94K | 1.04M | 1M | 1.12M | 1.52M | 1.34M | 971.81K | 594.4K | 50.16K | n/a | n/a | n/a | n/a | n/a | 715 | 58.08K |
Selling & Marketing Expenses | 723.94K | 638.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 169.22K | 368.34K | 368.34K | 608.2K | 744.08K | 683.29K | 823.54K | 713.89K | 544.33K | 542.59K | 523.36K | 491.19K | 444.49K |
Cost & Expenses | 2.88M | 1.61M | n/a | 7.17M | 7.01M | 7.07M | 5.76M | 6.71M | 8.21M | 11.65M | 15.53M | 16.69M | 19.74M | 20.13M | 20.56M | 23.26M | 23.39M | 26.34M | 28.32M | 28.9M | 27.5M | 22.46M |
Income Tax Expense | 2.56M | 2.56M | 2.56M | 5.57K | 3.37K | 2.16K | 3.91K | -6.42K | -4.22K | -41.19K | -206.75K | -201.58K | -432.35K | -388.73K | -224.22K | -221.31K | 10.47K | 5.63K | 5.43K | -756 | 538 | 530 |
Shares Outstanding (Basic) | 20.29M | 7.7M | 2.41M | 1.68M | 1.68M | 1.46M | 4.53M | 4.53M | 7.6M | 5.94M | 5.22M | 5.05M | 5.05M | 4.93M | 4.21M | 3.94M | 3.67M | 3.53M | 3.13M | 2.9M | 2.89M | 2.76M |
Shares Outstanding (Diluted) | 20.29M | 7.7M | 2.41M | 1.68M | 1.68M | 1.46M | 4.53M | 4.53M | 7.6M | 5.94M | 5.23M | 5.05M | 5.05M | 4.96M | 4.21M | 3.94M | 3.67M | 3.53M | 3.13M | 2.9M | 2.89M | 2.82M |
EPS (Basic) | -6.29 | -7.08 | -8.11 | -4.74 | -3.41 | -2.62 | -1.14 | -1.42 | -1.74 | -2.22 | -2.71 | -4.27 | -4.52 | -4.96 | -5.35 | -5.26 | -5.27 | -5.98 | -6.09 | -1.12 | -4.24 | -23.64 |
EPS (Diluted) | -6.29 | -7.08 | -8.11 | -4.74 | -3.41 | -2.62 | -1.14 | -1.42 | -1.74 | -2.22 | -2.71 | -4.26 | -4.51 | -4.95 | -5.34 | -5.26 | -5.27 | -5.98 | -6.06 | -1.09 | -4.21 | -23.61 |
EBITDA | -16.24M | -14.86M | -13.1M | -6.48M | -6.29M | -6.45M | -5.3M | -6.78M | -8.11M | -9.41M | -11.6M | -12.92M | -13.58M | -14.59M | -15.9M | -16.91M | -18.26M | -21.53M | -22.34M | -21.99M | -25.3M | -36.44M |
EBIT | -3.14M | -1.76M | n/a | -6.48M | -6.29M | -6.45M | -5.3M | -6.79M | -8.18M | -9.61M | -11.91M | -13.22M | -13.91M | -14.89M | -16.17M | -17.27M | -18.61M | -21.86M | -22.66M | -22.25M | -25.55M | -36.68M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | 1.12K | 2.25K | 6.74K | 70.6K | 192.26K | 307.44K | 305.99K | 331.68K | 300.71K | 268.65K | 353.01K | 345.4K | 331.12K | 321.06K | 262.03K | 259.09K | 264.43K |
Add to Watchlist
Select watchlists to add or remove QLGN